Clinical Features and Prognostic Factors for Dermatomyositis-Associated Interstitial Lung Diseases with Anti-MDA5 Antibody

被引:0
|
作者
Fujisawa, T. [1 ]
Hozumi, H. [1 ]
Yasui, H. [1 ]
Suzuki, Y. [1 ]
Karayama, M. [1 ]
Furuhashi, K. [1 ]
Enomoto, N. [1 ]
Nakamura, Y. [1 ]
Inui, N. [2 ]
Suda, T. [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka, Japan
[2] Hamamatsu Univ Sch Med, Deparmtne Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka, Japan
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1679
引用
下载
收藏
页数:1
相关论文
共 50 条
  • [31] Fatal interstitial lung disease and pneumocystis during dermatomyositis associated with anti-MDA5 antibodies
    Seiller, H.
    Schmutz, J. -L.
    Poreaux, C.
    Bursztejn, A. -C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2020, 147 (12): : 862 - 867
  • [32] The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
    Yumiko Sugiyama
    Ryusuke Yoshimi
    Maasa Tamura
    Mitsuhiro Takeno
    Yosuke Kunishita
    Daiga Kishimoto
    Yuji Yoshioka
    Kouji Kobayashi
    Kaoru Takase-Minegishi
    Toshiyuki Watanabe
    Naoki Hamada
    Hideto Nagai
    Naomi Tsuchida
    Yutaro Soejima
    Hiroto Nakano
    Reikou Kamiyama
    Takeaki Uehara
    Yohei Kirino
    Akiko Sekiguchi
    Atsushi Ihata
    Shigeru Ohno
    Shouhei Nagaoka
    Hideaki Nakajima
    Arthritis Research & Therapy, 20
  • [33] Anti-MDA5 dermatomyositis and progressive interstitial pneumonia
    Silveira, M. G.
    Selva-O'Callaghan, A.
    Ramos-Terrades, N.
    Arredondo-Agudelo, K. V.
    Labrador-Horrillo, M.
    Bravo-Masgoret, C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (01) : 49 - 50
  • [34] The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
    Sugiyama, Yumiko
    Yoshimi, Ryusuke
    Tamura, Maasa
    Takeno, Mitsuhiro
    Kunishita, Yosuke
    Kishimoto, Daiga
    Yoshioka, Yuji
    Kobayashi, Kouji
    Takase-Minegishi, Kaoru
    Watanabe, Toshiyuki
    Hamada, Naoki
    Nagai, Hideto
    Tsuchida, Naomi
    Soejima, Yutaro
    Nakano, Hiroto
    Kamiyama, Reikou
    Uehara, Takeaki
    Kirino, Yohei
    Sekiguchi, Akiko
    Ihata, Atsushi
    Ohno, Shigeru
    Nagaoka, Shouhei
    Nakajima, Hideaki
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [35] Assessing Time of Onset for Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis
    Lin, Rachel R.
    Warp, Peyton V.
    Maderal, Andrea D.
    Elman, Scott A.
    JAMA DERMATOLOGY, 2024, 160 (05) : 575 - 577
  • [36] Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
    Gono, Takahisa
    Sato, Shinji
    Kawaguchi, Yasushi
    Kuwana, Masataka
    Hanaoka, Masanori
    Katsumata, Yasuhiro
    Takagi, Kae
    Baba, Sayumi
    Okamoto, Yuko
    Ota, Yuko
    Yamanaka, Hisashi
    RHEUMATOLOGY, 2012, 51 (09) : 1563 - 1570
  • [37] Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5) Dermatomyositis-Associated Interstitial Lung Disease Complicated by Pneumomediastinum: A Case Report and Literature Review
    Chaudhary, Shivang
    Balagani, Amulya
    Zaheer, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [38] Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis
    Li, Liubing
    Wang, Qian
    Yang, Funing
    Wu, Chanyuan
    Chen, Si
    Wen, Xiaoting
    Liu, Chenxi
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (16) : 26552 - 26564
  • [39] Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease
    Kaenmuang, Punchalee
    Navasakulpong, Asma
    RESPIROLOGY CASE REPORTS, 2021, 9 (01):
  • [40] Anti-MDA5 Antibody Positive Dermatomyositis Is Not Always Associated with Recalcitrant Lung Disease or Mortality
    Soni, Dipekka
    Maniscalco, David
    Veeraraghavan, Srihari
    Cheeley, Justin
    Khosroshahi, Arezou
    ARTHRITIS & RHEUMATOLOGY, 2019, 71